RETRACTED: The Sarandria Score—Discussion of a New Scoring System in Clinical Medical Oncology

Nicola Sarandria

University of Padova, Padova, Italy.

DOI: 10.4236/ijcm.2022.133010                

Abstract

Short Retraction Notice

The paper has been retracted according to author’s withdrawal request. In making this decision the Editorial Board follows COPE's Retraction Guidelines. The aim is to promote the circulation of scientific research by offering an ideal research publication platform with due consideration of internationally accepted standards on publication ethics. The Editorial Board would like to extend its sincere apologies for any inconvenience this retraction may have caused.

Please see the article page for more details. The full retraction notice in PDF is preceding the original paper which is marked "RETRACTED".

Keywords

New Clinical Score, Sarandria Score, Methodology, Rectal Cancer, Neutrophils, 5-Fluorouracil, Neutrophils and Cancer, Colorectal Cancer

Conflicts of Interest

The author declares no conflicts of interest regarding the publication of this paper.

References

[1]	Sarandria, N. (2021) Neutrophils in Rectal Cancer—A Review: Stage III Rectal Cancer Patients and 5-Fluorouracil Therapy. Introducing New Inclusion Criteria and Scoring System (Presenting the “Sarandria Score”). Journal of Cancer Therapy, 12, 674-688. https://doi.org/10.4236/jct.2021.1212059
[2]	Sarandria, N. (2020) Occurrence and Clinical Significance of Tumor-Associated Neutrophils in Colorectal Cancer. Medical Graduation Thesis, Humanitas Unviersity, Pieve Emanuele.
[3]	Toms, J.R. (2004) CancerStats Monograph 2004. Cancer Research UK, London.
[4]	Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M. and Bos, J.L. (1988) Genetic Alterations during Colorectal-Tumor Development. The New England Journal of Medicine, 319, 525-532. https://doi.org/10.1056/NEJM198809013190901
[5]	Vogelstein, B. and Fearon, E.R. (1990) A Genetic Model for Colorectal Tumorigenesis. Cell, 61, 759-767.
[6]	Konishi, F. and Morson, B.C. (1982) Pathology of Colorectal Adenomas: A Colonoscopic Survey. Journal of Clinical Pathology, 35, 830-841. https://doi.org/10.1136/jcp.35.8.830
[7]	Colorectal Cancer: Statistics. Cancer.Net. https://www.cancer.net/cancer-types/colorectal-cancer/statistics#:~:text=The%205%2Dyear%20survival%20rate%20of%20people%20with%20localized%20stage,diagnosed%20at%20this%20early%20stage.&text=If%20colon%20cancer%20has%20spread,rate%20for%20people%20is%2067
[8]	Konishi, K., Fujii, T., Kato, S., et al. (1999) Clinicopathological Differences between Colonic and Rectal Carcinomas: Are They Based on the Same Mechanism of Carcinogenesis? Gut, 45, 818-821. https://doi.org/10.1136/gut.45.6.818
[9]	Baran, B., Ozupek, N.M., Tetik, N.Y., et al. (2018) Difference between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterology Research, 11, 264-273. https://doi.org/10.14740/gr1062w
[10]	Paschke, S., Jafarov, S., Staib, L., et al. (2018) Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. International Journal of Molecular Sciences, 19, Article No. 2577. https://doi.org/10.3390/ijms19092577
[11]	Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. https://doi.org/10.1016/S0140-6736(00)04046-0
[12]	Guo, G.F., et al. (2019) Immune Cell Concentrations among the Primary Tumor Microenvironment in Colorectal Cancer Patients Predicted by Clinicopathologic Characteristics and Blood Indexes. Journal for ImmunoTherapy of Cancer, 7, Article No. 179. https://doi.org/10.1186/s40425-019-0656-3
[13]	Mantovani, A., et al. (2002) Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes. Trends in Immunology, 23, 549-555. https://doi.org/10.1016/S1471-4906(02)02302-5
[14]	Kather, J.N. and Halama, N. (2019) Harnessing the Innate Immune System and Local Immunological Microenvironment to Treat Colorectal Cancer. British Journal of Cancer, 120, 871-882. https://doi.org/10.1038/s41416-019-0441-6
[15]	Fridlender, Z.G., et al. (2009) Polarization of Tumor-Associated Neutrophil (TAN) Phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell, 16, 183-194. https://doi.org/10.1016/j.ccr.2009.06.017
[16]	Mizuno, R., et al. (2019) The Role of Tumor-Associated Neutrophils in Colorectal Cancer. International Journal of Molecular Sciences, 20, Article No. 529. https://doi.org/10.3390/ijms20030529
[17]	Hicks, A.M., Riedlinger, G., Willingham, M.C., Alexander-Miller, M.A., Von Kap-Herr, C., Pettenati, M.J., Sanders, A.M., Weir, H.M., Du, W., Kim, J., et al. (2006) Transferable Anticancer Innate Immunity in Spontaneous Regression/Complete Resistance Mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 7753-7758. https://doi.org/10.1073/pnas.0602382103
[18]	Galdiero, M.R., et al. (2016) Occurrence and Significance of Tumor-Associated Neutrophils in Patients with Colorectal Cancer. International Journal of Cancer, 139, 446-456. https://doi.org/10.1002/ijc.30076
[19]	Apetoh, L. and Ghiringhelli, F. (2015) Enhancing the Anticancer Effects of 5-Fluorouracil: Current Challenges and Future Perspectives. Biomedical Journal, 38, 111-116. https://doi.org/10.4103/2319-4170.130923
[20]	Berry, R.S., Xiong, M.J., Greenbaum, A., et al. (2017) High Levels of Tumor-Associated Neutrophils Are Associated with Improved Overall Survival in Patients with Stage II Colorectal Cancer. PLoS ONE, 12, e0188799. https://doi.org/10.1371/journal.pone.0188799